abstract |
The invention relates to pharmaceutical compositions that contain arsenic trioxide and at least one long-chain, polyunsaturated fatty acid. The invention further relates to the use of arsenic trioxide and at least one long-chain, polyunsaturated fatty acid for the therapeutic treatment of a malign degeneration, especially for the treatment of leukemia, promyelocytic leukemia, secondary resistant promyelocytic leukemia and/or primary resistant leukemia or for the treatment of a solid tumor such as a liver carcinoma or renal carcinoma. |